When immunotherapy mimics pancreatic cancer: mass-forming immune-related pancreatitis during neoadjuvant treatment for triple-negative breast cancer.

Mouchet M, Gourmaud J, Kamel ME, Courtès MG

Open source

DOI
10.1136/bcr-2026-274710
Published
2026 Sep 24
Container
BMJ case reports
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bcr-2026-274710,
  title = {When immunotherapy mimics pancreatic cancer: mass-forming immune-related pancreatitis during neoadjuvant treatment for triple-negative breast cancer.},
  author = {Mouchet M and Gourmaud J and Kamel ME and Courtès MG},
  year = {2026},
  journal = {BMJ case reports},
  doi = {10.1136/bcr-2026-274710},
  url = {https://doi.org/10.1136/bcr-2026-274710}
}

RIS

TY  - JOUR
TI  - When immunotherapy mimics pancreatic cancer: mass-forming immune-related pancreatitis during neoadjuvant treatment for triple-negative breast cancer.
AU  - Mouchet M
AU  - Gourmaud J
AU  - Kamel ME
AU  - Courtès MG
PY  - 2026
JO  - BMJ case reports
DO  - 10.1136/bcr-2026-274710
UR  - https://doi.org/10.1136/bcr-2026-274710
ER  - 

APA

M, M., J, G., ME, K., & MG, C. (2026). When immunotherapy mimics pancreatic cancer: mass-forming immune-related pancreatitis during neoadjuvant treatment for triple-negative breast cancer.. BMJ case reports. https://doi.org/10.1136/bcr-2026-274710

Source records